Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations

Since its first use in 1952, human immunoglobulin has been used to treat people who have inherited antibody deficiencies. This article summarizes IVIG clinical development in primary immunodeficient patients and manufacturing improvements introduced over time. Manufacturing improvements include puri...

Descripción completa

Detalles Bibliográficos
Autor principal: Hooper, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135658/
https://www.ncbi.nlm.nih.gov/pubmed/18940573
http://dx.doi.org/10.1016/j.iac.2008.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135658/
https://www.ncbi.nlm.nih.gov/pubmed/18940573
http://dx.doi.org/10.1016/j.iac.2008.06.002

Ejemplares similares